This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kansas State University Research Foundation. Active years: 2015-2017.
Company Filing History:
Years Active: 2015-2017
Title: Innovations of Matthew T Basel
Introduction
Matthew T Basel is an accomplished inventor based in Manhattan, Kansas. He has made significant contributions to the field of diagnostics, particularly in the assessment of protease activity. With a total of four patents to his name, Basel's work is paving the way for advancements in cancer detection and prognosis.
Latest Patents
One of his latest patents is a diagnostic reagent or assay for assessing the activity of a protease in vivo or in vitro. This invention provides methods for detecting the presence of cancerous or precancerous cells. The assays consist of two particles linked via an oligopeptide linkage that includes a consensus sequence specific for the target protease. Cleavage of this sequence by the target protease can be detected visually or using various sensors, allowing for diagnostic results that can be correlated with cancer prognosis.
Career Highlights
Matthew T Basel is affiliated with the Kansas State University Research Foundation, where he continues to innovate and contribute to research in his field. His work is characterized by a commitment to improving diagnostic methods and enhancing patient outcomes.
Collaborations
Some of his notable coworkers include Stefan H Bossmann and Deryl L Troyer, who collaborate with him on various research projects and innovations.
Conclusion
Matthew T Basel's contributions to the field of protease assays and cancer diagnostics highlight his role as a leading inventor in this important area of research. His work continues to influence advancements in medical diagnostics and patient care.